Nature Communications (Jun 2017)

VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2

  • Yao-Hui Gao,
  • Zhao-Xia Wu,
  • Li-Qi Xie,
  • Cai-Xia Li,
  • Yu-Qin Mao,
  • Yan-Tao Duan,
  • Bing Han,
  • San-Feng Han,
  • Yun Yu,
  • Hao-Jie Lu,
  • Peng-Yuan Yang,
  • Tian-Rui Xu,
  • Jing-Lin Xia,
  • Guo-Qiang Chen,
  • Li-Shun Wang

DOI
https://doi.org/10.1038/ncomms15337
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 14

Abstract

Read online

The VHL tumour suppressor gene is lost in approximately 70% of clear cell renal cell carcinoma (ccRCC). In this study, the authors demonstrate that VHL loss in these tumours augments anthracyclines chemotherapy by down-regulation of ALDH2.